Frontlight ResearchEarly access
Taking people in United StatesNo phase
fMRI and Opioid Abstinence
Key facts
- Who runs it
- Yale University
- Where
- Hartford and New Haven, United StatesSee the 2 sites
- Trial code
- Status
- Recruiting
- People taking part
- 240 people, planned
- Started
- 12 Dec 2024
- Expected to end
- Nov 2029
- Type of study
- Observational, 2 groups
- Treatments tested
- fMRI
- Record updated
- 7 August 2026
Who can take part
- Age
- 18 years to 50 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- recent initiation of methadone or buprenorphine at a clinic, program, or doctor within the past year (i.e., period of time during which treatment drop-out and risk for relapse is highest)
- eligibility for MRI scanning
- ability to commit to study visits
Who cannot take part
- severe cognitive impairment as determined via trained clinical research staff through consent process and during consent quiz or as indicated by a PROMIS Cognitive Function tscore <30 (i.e., severe impairment)
- past or present history of intellectual disability, developmental disorder, or neurological disease
- organ dysfunction or any unstable or untreated medical conditions that may interfere with study participation
- current acute psychosis, mania, or suicidal ideation with intent, as assessed during screening with the SCID-5
- current intoxication or acute withdrawal at time of study visit sufficient to prevent participation based on: behavioral observation, breathalyzer, and SOWS assessment
- head trauma with loss of consciousness >30 min
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 18 and 50 years old?
This trial is currently available in United States.
- Hartford HealthcareHartford, United StatesContact: Monica HollerTaking people
- The APT FoundationNew Haven, United StatesContact: Monica HollerTaking people
About the trial
What the trial wants to find out
This project examines functional connectivity patterns associated with subsequent relapse to illicit opioids during treatment for OUD.
The 2 groups in the trial
- Methadone
Participants initiated into methadone within the past 6 months will receive fMRI and cognitive assessment battery.
Treatment: fMRI
- Buprenorphrine
Participants initiated into buprenorphine within the past 6 months will receive fMRI and cognitive assessment battery.
Treatment: fMRI
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Functional Connectivity Mechanisms of Opioid Abstinence
- Criteria questions
- Built from NCT06651333, who can take part
- Record updated
- 7 August 2026